Toxicological Profile for Plutonium
Yüklə 4,8 Kb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- APPENDIX E. INDEX
PLUTONIUM D-14 APPENDIX D ICRP. 1984. International Commission on Radiological Protection. A compilation of the major concepts and quantities in use by ICRP. ICRP Publication 42. Oxford: Pergamon Press. ICRP. 1990. International Commission on Radiological Protection 1990 Recommendations of the ICRP ICRU. 1980. International Commission on Radiation Units and Measurements. ICRU Report No. 33. Washington, DC. James A. 1987. A reconsideration of cells at risk and other key factors in radon daughter dosimetry. In: Hopke P, ed. Radon and its decay products: Occurrence, properties and health effects. ACS Symposium Series 331. Washington, DC: American Chemical Society, 400-418. James A, Roy M. 1987. Dosimetric lung models. In: Gerber G, et al., ed. Age-related factors in radionuclide metabolism and dosimetry. Boston: Martinus Nijhoff Publishers, 95-108. Kondo S. 1993. Health effects of low-level radiation. Kinki University Press, Osaka, Japan (available from Medical Physics Publishing, Madison, Wisconsin). Kato H, Schull W. 1982. Studies of the mortality of A-bomb survivors. Report 7 Part 8, Cancer mortality among atomic bomb survivors, 1950-78. Radiat Res 90;395-432. Mettler F, Moseley R. 1985. Medical effects of ionizing radiation. New York: Grune and Stratton. NCRP. 1971. Basic radiation protection criteria. National Council on Radiation Protection and Measurements. Report No. 39. Washington, DC. NCRP. 1985. A handbook of radioactivity measurements procedures. 2nd ed. National Council on Radiation Protection and Measurements. Report No. 58. Bethesda, MD: NCRP. 1993. Risk estimates for radiation protection. National Council on Radiation Protection and Measurements. Report 115. Bethesda, Maryland Otake M, Schull W. 1984. Mental retardation in children exposed in utero to the atomic bombs: A reassessment. Technical Report RERF TR 1-83, Radiation Effects Research Foundation, Japan. Rubin P, Casarett G. 1968. Clinical radiation pathology. Philadelphia: W.B. Sanders Company, 33. UNSCEAR. 1977. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. New York: United Nations. UNSCEAR. 1982. United Nations Scientific Committee on the Effects of Atomic Radiation. Ionizing radiation: Sources and biological effects. New York: United Nations. UNSCEAR. 1986. United Nations Scientific Committee on the Effects of Atomic Radiation. Genetic and somatic effects of ionizing radiation. New York: United Nations. UNSCEAR. 1988. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, effects and risks of ionization radiation. New York: United Nations. PLUTONIUM D-15 APPENDIX D UNSCEAR. 1993. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. New York: United Nations. USNRC. 1999. Standards for the protection against radiation, table 1004(b).1. 10 CFR 20.1004. U.S. Nuclear Regulatory Commission, Washington, D.C. PLUTONIUM D-16 APPENDIX D This page is intentionally blank. PLUTONIUM E-1 APPENDIX E. INDEX absorbed dose.......................................................................................................................... 20, 55, 62, 128 activity median aerodynamic diameter (see AMAD) ................................................................... 25, 73, 211 adenocarcinomas................................................................................................................................... 13, 62 adsorbed.................................................................................................................... 165, 166, 168, 191, 204 adsorption.................................................................................................................................................. 168 alanine aminotransferase (see ALT) ........................................................................................................... 50 ALI (see annual limits on intake).............................................................................. 207, 208, 209, 210, 211 ALT (see alanine aminotransferase) ........................................................................................................... 50 AMAD (activity median aerodynamic diameter) ................. 14, 24, 25, 43, 61, 73, 74, 75, 80, 86, 131, 211 ambient air ................................................................................................................................ 167, 188, 192 annual limits on intake (see ALI).............................................................................................................. 207 bioaccumulation........................................................................................................................................ 191 bioconcentration factor ............................................................................................................................. 170 biokinetic .............................................................................................................................. 20, 91, 110, 144 biomarker .................................................................................................................. 127, 128, 142, 195, 205 blood cell count..................................................................................................................................... 14, 48 breast milk......................................................................................................................................... 188, 192 cancer........................4, 10, 11, 12, 13, 14, 15, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 45, 49, 50, 54, 56, 58, 59, 60, 61, 62, 64, 66, 70, 126, 129, 131, 136, 138, 139, 140, 141, 142, 207, 213 carcinogen................................................................................................................................................. 211 carcinogenic ........................................................................................................................................ 21, 211 carcinogenicity............................................................................................................................................ 78 carcinoma ................................................................................................................................ 13, 62, 63, 130 carcinomas .......................................................................................................................................... 62, 130 cardiac arrhythmia ...................................................................................................................................... 52 cardiovascular ..................................................................................................................... 16, 46, 64, 65, 86 cardiovascular effects............................................................................................................................ 16, 46 chromosomal aberrations................................................................................................ 66, 69, 70, 140, 141 clearance ............................................... 25, 73, 75, 86, 88, 91, 93, 95, 98, 99, 110, 112, 113, 122, 129, 211 DAC (see derived air concentration) ........................................................................................ 207, 210, 211 death........... 13, 21, 25, 28, 29, 30, 31, 32, 35, 36, 43, 44, 45, 52, 58, 59, 60, 61, 62, 63, 64, 65, 71, 78, 140 derived air concentration (see DAC) ........................................................................................................ 207 elimination half-time................................................................................................................................... 86 elimination rate ........................................................................................................................................... 76 endocrine............................................................................................................................................. 52, 124 endocrine effects ......................................................................................................................................... 52 erythema...................................................................................................................................................... 19 fetus................................................................................................................................. 5, 82, 125, 141, 208 fractional absorption ........................................................................................................... 76, 122, 139, 140 gastrointestinal effects .............................................................................................................. 16, 46, 47, 64 general population................................................................................................................. 3, 5, 10, 78, 207 genotoxic............................................................................................................................... 21, 66, 128, 140 genotoxicity..................................................................................................................................... 66, 69, 71 geometric standard deviation (see GSD) .................................................................................................... 73 groundwater ...................................................................................................... 163, 164, 166, 168, 175, 176 GSD (see geometric standard deviation) .................................................................................. 73, 74, 85, 86 half-life...................................................................................................... 2, 88, 98, 105, 127, 145, 170, 190 hematological effects .......................................................................................................... 14, 47, 48, 49, 53 hematopoietic................................................................................................................ 14, 23, 27, 28, 47, 60 Yüklə 4,8 Kb. Dostları ilə paylaş:
|